Vital Therapies reported $3K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Dynavax Technologies DVAX:US $ 0.13M 0M
Enanta Pharmaceuticals ENTA:US $ 0.21M 0M
Epizyme EPZM:US $ 0.02M 0M
Insmed INSM:US $ 1.2M 6K
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Orasure Technologies OSUR:US $ 0M 0M
Revance Therapeutics RVNC:US $ 0.07M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 86K 0